Emilia McLaughlin

Emilia McLaughlin has a strong background in biochemistry and molecular biology, with experience in research, lecturing, event coordination, and entrepreneurship. Currently, Emilia is the founder of kyron.bio, a company focused on revolutionizing drug production. Emilia holds a PhD in Cell and Molecular Biology from the prestigious Pasteur Institute and has received multiple research grants for their work. Emilia's experience includes internships at companies like Amgen and the Zoological Society of London, where Emilia conducted research on malaria vaccines and amphibian pathogens, respectively. Emilia's diverse experiences and education highlight their expertise in the field of biotechnology.